A detailed history of Covestor LTD transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 6 shares of ITOS stock, worth $49. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 6 -0.0%
Holding current value
$49
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$8.57 - $11.06 $8 - $11
-1 Reduced 14.29%
6 $0
Q3 2023

Nov 13, 2023

BUY
$10.95 - $14.6 $32 - $43
3 Added 75.0%
7 $0
Q4 2022

Feb 13, 2023

SELL
$17.77 - $21.6 $17 - $21
-1 Reduced 20.0%
4 $0
Q3 2022

Nov 14, 2022

SELL
$18.6 - $27.25 $2,622 - $3,842
-141 Reduced 96.58%
5 $0
Q2 2022

Aug 10, 2022

BUY
$16.57 - $35.1 $2,154 - $4,563
130 Added 812.5%
146 $3,000
Q1 2022

May 13, 2022

BUY
$31.92 - $47.45 $510 - $759
16 New
16 $1,000
Q4 2021

Feb 10, 2022

BUY
$26.23 - $47.86 $0 - $0
0 New
0 $0

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.